15 results on '"Di Rubbo, V."'
Search Results
2. Concha bullosa related headache disability
- Author
-
Cantone E, Castagna G, Ferranti I, Cimmino M, Sicignano S, Rega F, Di Rubbo V, maurizio iengo, Cantone, E, Castegna, G, Ferranti, I, Cimmino, M, Sicignano, S, Rega, F, Di Rubbo, V, and Iengo, Maurizio
- Subjects
Quality of life ,Adult ,Male ,Medicine (all) ,Headache ,Rhinology ,Middle Aged ,Plastic Surgery Procedures ,Turbinate surgery ,Turbinates ,Nasal Mucosa ,Young Adult ,Nasal Polyps ,Nose Diseases ,Humans ,Pharmacology (medical) ,Female ,Nasal Cavity ,Aged ,Pain Measurement - Abstract
Rhinogenic headache (RH) is a headache or facial pain syndrome secondary to mucosal contact points in the sino-nasal cavities, in the absence of inflammatory signs, hyperplastic mucosa, purulent discharge, sino-nasal polyps or masses. It may result from pressure on the nasal mucosa due to anatomical variations among which the pneumatization of the middle turbinate, concha bullosa, a variant of the development of ethmoidal cells, is the most commonly observed. Clinical practice suggests a close correlation between concha bullosa, mucosal contacts and rhinogenic headache, with high impact on the QoL. However diagnostic and therapeutic difficulties still remain. Aim of the present study is to evaluate the impact of medical or surgical care on the QoL of patients suffering from concha bullosa related headache from the patients' perspective.One-hundred-two subjects with concha bullosa and headache anamnesis were randomized into two groups and given medical or surgical treatment. To assess the Quality of life (QoL) we used visual analogue scale and for the first time, the migraine disability score before and after treatment.After treatment the severity of the headache decreased as well as the discomfort in the surgical group compared with medical group.The improvement of symptoms and QoL suggests that the endoscopic surgical plastic may promote the rapid resolution of concha bullosa related headache improving the and reducing health care costs.
- Published
- 2015
3. Asymmetric hearing loss and vertigo in a patient with idiopathic normal pressure hydrocephalus
- Author
-
Eibenstein, A., Varakliotis, T., Maspes, F., Di Rubbo, V., Cisternino, S., Vitti, E., Lauriello, M., and Di Girolamo, S
- Published
- 2017
4. Impact of intranasal sodium hyaluronate on the short-term quality of life of patients undergoing functional endoscopic sinus surgery for chronic rhinosinusitis
- Author
-
Cantone E, Castagna G, Sicignano S, Ferranti I, Rega F, Di Rubbo V, IENGO, MAURIZIO, Cantone, E, Castagna, G, Sicignano, S, Ferranti, I, Rega, F, Di Rubbo, V, and Iengo, Maurizio
- Published
- 2014
5. Ruolo del diabete di tipo 2 come fattore di rischio del carcinoma laringeo: studio pilota
- Author
-
Ferranti I., Di Rubbo V., Sicignano S., Rega F., Cantone E., MESOLELLA, MASSIMO, IENGO, MAURIZIO, Camaioni A., Ferranti, I., Di Rubbo, V., Sicignano, S., Rega, F., Cantone, E., Mesolella, Massimo, and Iengo, Maurizio
- Published
- 2013
6. A novel approach to manage recurrent epistaxis in outpatients with hereditary hemorrhagic telangiectasia
- Author
-
Vittoria Di Rubbo, Felice Rega, Maurizio Iengo, Giovanni Castagna, Elena Cantone, Anna Marino, Stefania Sicignano, Cantone, E, Marino, A, Castagna, G, Sicignano, S, Rega, F, Di Rubbo, V, and Iengo, Maurizio
- Subjects
Male ,medicine.medical_specialty ,Hemostatic Techniques ,business.industry ,Treatment outcome ,Genetic Diseases, Inborn ,Thrombin ,General Medicine ,Middle Aged ,Hemostatic technique ,Recurrent epistaxis ,Surgery ,Epistaxis ,Treatment Outcome ,Recurrence ,Emergency Medicine ,medicine ,Gelatin ,Humans ,Female ,Telangiectasia, Hereditary Hemorrhagic ,medicine.symptom ,Telangiectasia ,business ,Administration, Intranasal - Abstract
Hereditary hemorrhagic telangiectasia (HHT), or Rendu-Osler-Weber syndrome, is characterized by telangiectasic vascular malformations of the skin and of the digestive and respiratory mucosa. Epistaxis is the most common otorhinolaryngologic manifestation, with potential complications as septal perforations and, in cases of serious bleeding, anemia. Given that some therapeutic approaches are burdened by failure, whereas others are invasive and painful, the possibility of using simple and effective approaches to manage recurrent epistaxis, especially in outpatients, is needed and useful. Recently, the use of Surgiflo, (OMRIX biopharmaceuticals Ltd.MDA Blood Bank, Ramar-GanPOB, Kiryat Ono, Israel) a gelatin-thrombin matrix, currently used as an alternative to the nasal packing, has been proposed. We evaluated the effectiveness of Surgiflo in the treatment of recurrent epistaxis in outpatients with HHT. The present investigation reports the case of 3 patients with recurrent HHT-related epistaxis treated with Surgiflo. We also review the literature discussing available treatment options. Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome, is a rare systemic fibrovascular dysplasia with autosomal-dominant inheritance. It is characterized by a spectrum of telangiectasic vascular malformations occurring in the skin and in the digestive and respiratory mucosa. Other manifestations of HHT occur in the lungs, liver, or central nervous system [1] and [2]. Otorhinolaryngologic manifestations are frequent, and epistaxis caused by spontaneous bleeding of nasal mucosa telangiectasis is the most common. The potential complications of epistaxis are septal perforations and, in cases of serious bleeding, anemia [3]. Treatment of HHT is aimed at controlling symptoms. For instance, it is possible to stop nose bleeding by applying direct pressure to the nose or performing anterior and/or posterior packing [4] and [5]. If these measures are insufficient and the frequency and duration of episodes impair the patient's quality of life, surgical cauterization, photocoagulation laser, or septal mucosal dermoplasty may be recommended [1] and [6]. To prevent the onset of chronic anemia resulting from severe epistaxis, the endovascular treatment with microembolization could be performed. Chemical cauterization should always be avoided because it may harm nasal structures [1]. Although brachytherapy and fibrin glue injection in the nasal septum and inferior turbinates submucosa are efficacious, they bring about only temporary symptom improvement [3]. Given that some therapeutic approaches are burdened by failure and some others are invasive and painful, the possibility of using simple and effective approaches to manage recurrent epistaxis, especially in hematology units and in outpatients, is needed and useful. Recently, the use of Surgiflo, a gelatin-thrombin matrix, currently used in neurosurgery and in thoracic and vascular surgery, has been proposed as an alternative to the nasal packing after functional endoscopic sinus surgery. In addition, some authors have evaluated the use of Surgiflo in the management of recurrent epistaxis [4] and [7]. Therefore, we evaluated the effectiveness of Surgiflo in the treatment of recurrent epistaxis in patients with HHT. The present investigation reports 3 cases of outpatients with recurrent HHT-related epistaxis treated with Surgiflo. We also review the literature discussing available treatment options. Surgiflo is a dehydrated gelatin-thrombin matrix in a syringe. For intranasal use, its gelatinous consistency must be maintained to remain in the nasal cavity (reconstitution with up to 3.5 to 4 mL of sterile water). A 16-cm-long applicator is put through the nasal vestibule to the rhinopharynx. The rhinopharynx and the nasal cavity are filled in with Surgiflo from back to front. A.V., female, 63 years old, had been complaining of mild recurrent epistaxis for 20 years, with worsening in the 6 months before treatment. She did not use salicylate-based drugs. The patient underwent cauterization of varices of the base of the tongue 7 years before and of the nasal septum 1 year before, with many anterior packings, followed by immediate epistaxis after each packing removal. The patient was transferred to ENT consultation in April 2011; nasal endoscopy showed crusts and hematic points spread throughout nasal septal mucosa. Blood test showed hemoglobin (Hb) levels of 10.50 g/dL and iron levels of 29 μg/dL. Surgiflo was applied inside both nasal cavities through nasal endoscopy without anesthesia, and the patient left the hospital after 2 hours of monitoring without recurrence of bleeding. No epistaxis has recurred until now. G.C., male, 49 years old with HHT, had been complaining of a right anterior epistaxis for 5 years. He underwent repeated right anterior packings that were effective, but bleeding recurrences were immediate after each packing removal. Nasal endoscopy showed hematic points throughout the right nasal cavity. Blood tests showed Hb levels of 10.90 g/dL and iron levels 33 μg/dL. In September 2011, he was treated with Surgiflo without anesthesia. The patient left the hospital after 2 hours of monitoring without bleeding. No epistaxis has recurred until now. G.E., male, 62 years old, was affected by HHT; he had been complaining of epistaxis for 7 years, treated by repeated anterior packings followed by immediate bleeding recurrences. During his physical examination at ENT Unit, we noticed hematic points spread throughout nasal septum. Blood tests showed Hb levels of 10.30 g/dL and iron levels 30 μg/dL. We applied Surgiflo in July 2012 inside his nasal mucosa through nasal endoscopy without anesthesia. The patient left the hospital after 2 hours of monitoring without bleeding. No epistaxis has recurred until now. Epistaxis is the earliest and the most common symptom of HHT. Ninety-five percent of individuals with HHT experience recurrent epistaxis, with a mean frequency of 18 episodes per month [1]. Although the nasal packing allows stopping most of bleedings, the disadvantages of local infections, septic complications, pain, mucosal traumatism, and bleeding recurrence still remain. An alternative to the traditional packing could be the use of absorbable packing such as Surgicel (ETHICON, LLC San Lorenzo, Puerto Rico) (oxidized cellulose polymer) or Gelfoam (Pharmacia and Upjohn Company, Kalamazoo, MI, USA) (absorbable gelatin sponge), whose placement is, anyhow, painful in outpatients and less effective for posterior bleeding [4]. For instance, some authors have evaluated the use of the gelatin-thrombin matrix after functional endoscopic sinus surgery with encouraging outcomes, reporting the prevention of bleeding after surgery in 96.7% of cases [7]. Furthermore, Buiret et al [4] report the cases of 2 patients, one with thrombocytopenia and the other with thrombopathy, hospitalized for recurrent epistaxis and, after repeated failed treatments, successfully treated with local application of Surgiflo. In the present study, we report 3 cases of patients with recurrent HHT-related epistaxis treated with Surgiflo. Our preliminary encouraging findings suggest that the use of local application of gelatin-thrombin matrix could be an effective alternative to the traditional anterior/posterior nasal packing, especially in outpatients at higher risk for bleeding, in which often the bleeding occurs again after the removal of nasal packing. Moreover, this technique is not invasive or potentially dangerous for outpatients. Surgiflo is effective, repeatable over time, and easy to apply, even without anesthesia. In addition, it could avoid the use of surgical procedures such as cauterization. In our opinion, Surgiflo can represent a valid tool for the management recurrent epistaxis in HHT, particularly in outpatients, because it is free of disadvantages related to the anterior packing or surgical procedures, effective, and reabsorbable. Furthermore, the cost of this device is widely offset by the reduction of hospitalization [4].
- Published
- 2014
7. Masseteric-facial anastomosis and hypoglossal-facial anastomosis after lateral skull base and middle ear surgery.
- Author
-
Lauda L, Sykopetrites V, Caruso A, Maddalone E, Di Rubbo V, Copelli C, and Sanna M
- Subjects
- Humans, Female, Male, Middle Aged, Adult, Aged, Young Adult, Treatment Outcome, Postoperative Complications, Retrospective Studies, Adolescent, Nerve Transfer methods, Facial Paralysis surgery, Facial Paralysis etiology, Facial Nerve surgery, Hypoglossal Nerve surgery, Skull Base surgery, Ear, Middle surgery, Anastomosis, Surgical methods
- Abstract
Introduction: Lateral skull base (LSB) and middle ear pathologies often involve the facial nerve (FN), and their treatment may require FN sacrifice. Cases with unidentifiable proximal stump or intact FN with complete FN palsy, necessitate FN anastomosis with another motor nerve in order to restore innervation to the mimicking musculature. The results of hypoglossal-to-facial nerve anastomosis (HFA) and masseteric-facial nerve anastomosis in patients with facial paralysis after middle ear and LSB surgeries, are presented and compared., Methods: Adult patients with total definitive facial paralysis after middle ear or LSB surgery undergoing facial nerve reanimation through hypoglossal or masseteric transfer anastomosis were enrolled. The facial nerve function was graded according to the House Brackmann grading system (HB). The facial function results at 3 months, 6 months, 12 months, 18 months and at the last follow up (more than 18 months) are compared., Results: 153 cases of LSB and middle ear surgery presented postoperative facial palsy and underwent facial nerve reanimation surgery with HF in 85 patients (55.5%) and MF in 68 patients (44.5%). The duration of the FN palsy before reconstructive surgery was inversely associated to better FN results, in particular with having a grade III HB (p = 0.003). Both techniques had significantly lower HB scores when an interval between palsy onset and reanimation surgery was 6 months or less (MF p = 0.0401; HF p = 0.0022). Patients who underwent a MF presented significant improvement of the FN function at 3 months from surgery (p = 0.0078). At the last follow-up, 63.6% recovered to a grade III HB and 22.7% to a grade IV. On the other hand, the first significant results obtained in the HF group were at 6 months from surgery (p < 0.0001). 67.8% of patients had a grade III HB after a HF at the last follow-up, 28.8% a grade IV. FN grading at 6 months from surgery was significantly lower in the MF group compared to the HF (p = 0.0351). The two techniques had statistically similar results at later follow-up evaluations., Discussion/conclution: MF was associated to initial superior results, presenting significant facial recovery at 3 months, and significantly better functional outcomes at 6 months from surgery compared to HF. Although later results were not significantly different in this study, earlier results have an important role in order to limit the duration of risk of corneal exposure., Competing Interests: Declarations Conflicts of interest The authors have no conflicts of interest to declare. Ethical approval This study protocol was reviewed and approved by the institutional review board of the Casa di Cura Privata Piacenza, Piacenza, Italy. Consent to participate All patients gave informed consent on the use of their data., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
8. Late complications of cochlear implant: a case report of necrotizing meningoencephalitis similar to a CPA tumor.
- Author
-
Di Rubbo V, Morelli L, Zangrandi A, Lauda L, Piras G, and Sanna M
- Subjects
- Humans, Child, Magnetic Resonance Imaging methods, Cochlear Implants adverse effects, Hearing Loss, Functional surgery, Cochlear Implantation adverse effects, Cochlear Implantation methods, Neuroma, Acoustic surgery, Neuroma, Acoustic pathology, Meningoencephalitis diagnosis, Meningoencephalitis etiology, Meningoencephalitis surgery
- Abstract
Objective: Report a case of localized necrotizing meningoencephalitis as the cause of functional hearing loss after cochlear implant (CI) surgery., Case Report: A 12-year-old with bilateral CI presented to our quaternary center due to severe functional hearing loss after 11 years since left ear CI surgery. CT with contrast was conducted showing a CPA tumor-like mass. Pre-operative computed tomography (CT) scans and magnetic resonance imaging (MRI) performed at the age of 1 year showed no inner ear abnormalities and in particular no evidence of a tumor in the cerebellopontine angle (CPA)., Conclusion: Following removal of the CI and the mass, histopathological, immunohistochemical and cultural examinations revealed a necrotizing meningoencephalitis, with the CI electrode as the focus., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
9. Management of Vestibular Schwannoma with Normal Hearing.
- Author
-
Salem N, Galal A, Piras G, Sykopetrites V, Di Rubbo V, Talaat M, Sobhy O, and Sanna M
- Subjects
- Humans, Retrospective Studies, Treatment Outcome, Hearing physiology, Prognosis, Postoperative Complications, Facial Nerve surgery, Neuroma, Acoustic surgery
- Abstract
Introduction: This work aimed to study the management of vestibular schwannoma (VS) patients with normal hearing (NH)., Methods: A retrospective study was undertaken in a Quaternary referral center for skull base pathologies. Among 4,000 VS patients 162 met our strict audiological criteria for NH. These patients were divided into 2 management groups, wait and scan (W&S) (45/162, 25%) and operated patients (123/162, 75%), and 6 patients were included in both groups., Results: Our management strategy achieved the goals for treatment of VS. First goal, all tumors were completely removed except for 2 intentional residuals. Second goal, facial nerve (FN) function preservation (House Brackmann I, II, and III) was 95.9%. Third goal, possible hearing preservation (HP) attempts occurred in (50/122) (40.9%) with an HP rate in 44% of the patients. Additionally, there were only 2 cases of postoperative complications with no CSF leakage. The prospect of HP in NH patients did not differ with respect to tumor size. However, patients with normal preoperative ABR seemed to have better chances of HP and good FN function and vice versa. HP rate was superior for the MCFA as opposed to the RS + RLA. W&S group demonstrated hearing stability in 88.9% of the patients and FN function stability of HB I in 100% of the patients., Conclusions: Surgical resection is a reasonable and definitive management option for VS with NH. Nevertheless, choosing to manage cases with observation remains an appropriate management option for NH patients. ABR might be considered as an adjuvant tool indicating better prognosis for HP., (© 2022 S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
10. Surgical Labyrinthectomy and Cochlear Implantation in Menière's Disease.
- Author
-
Sykopetrites V, Giannuzzi AL, Lauda L, Di Rubbo V, Bassi M, and Sanna M
- Subjects
- Aged, Humans, Retrospective Studies, Cochlear Implantation, Hearing Loss etiology, Hearing Loss surgery, Meniere Disease surgery, Otologic Surgical Procedures
- Abstract
Objective: The aim of this study was to analyze the results of labyrinthectomy and cochlear implantation (CI) on hearing, vertigo, and tinnitus and evaluate the adequacy of labyrinthectomy and CI for the treatment of end stage Menière's Disease (MD)., Study Design: Retrospective case review., Setting: Tertiary referral center., Patients: Charts of 22 patients undergoing labyrinthectomy and CI in the same ear for intractable vertigo and hearing loss with both preoperatory and postoperatory documentation available, were reviewed., Intervention(s): Therapeutic., Main Outcome Measure(s): Auditory outcomes were assessed with pure tone and speech audiometry, and compared with the preoperatory audiometric evaluation. Dizziness was graded according to the Dizziness Handicap Inventory Questionnaire (DHI). Tinnitus outcomes were assessed by the tinnitus handicap inventory (THI)., Results: Post-CI pure tone average had a statistically significant improvement (p = 0.035, paired t test). Speech audiometry resulted in a non-statistically significant speech discrimination score variation (p = 0.056, paired t test). Postoperatory THI had a statistically significant variation (p = 0.0001, paired t test). Sixty seven per cent of the patients had complete resolution of the vestibular symptoms in their operated ear, however, patients over 70 years old had significantly more failures as evinced by the postoperative DHI (p = 0.0109, Fisher's exact test)., Conclusions: Patients affected by end stage MD or secondary MD, with vertigo and severe hearing loss can successfully undergo labyrinthectomy and CI. Caution should be reserved in elderly patients for a risk of persistent instability. The CI confers significant benefit in hearing rehabilitation and tinnitus suppression.
- Published
- 2020
- Full Text
- View/download PDF
11. Correlation Between SNOT-22, Nasal Cytology, and Mood Disorders in Patients With Allergic Rhinitis Treated With a Liposomal Nasal Spray.
- Author
-
Lauriello M, Di Rubbo V, Sinatti G, Pasqua M, Tucci C, di Marco GP, Necozione S, and Eibenstein A
- Abstract
Patients with allergic rhinitis (AR) can suffer from mood disorders. The aim of this study was to investigate the clinical effect of a liposomal nasal spray (LN) containing vitamins A and E on the nasal mucosa in patients suffering from AR who had refused any type of anti-allergic treatment. For this purpose, the results of nasal cytology, Visual Analog Scale (VAS), Sino-Nasal Outcome Test-22 (SNOT-22), and Hospital Anxiety and Depression Scale (HADS) test were analyzed. Moreover, we evaluated the relationship between SNOT-22 and nasal cytology and between nasal symptoms and HADS scores. Statistical analysis revealed a significant decrease of scores at T1 in the LN treatment group as concerns VAS, SNOT-22, HADS-Anxiety test and a remarkable reduction of inflammatory cells detected with nasal cytology. Our study showed that higher levels of SNOT-22 corresponded to a higher level of HADS-Anxiety. The mechanisms underlying this relationship in AR patients are currently unknown, but we can suppose that improving mucosal trophism may contribute to the decrease of nasal symptoms and anxiety scores. The improvement of nasal symptoms, as measured by SNOT-22, was significantly correlated with the objective results of nasal cytology. These relationships between SNOT-22 and nasal cytology and between anxiety and cytology were investigated for the first time in our research.
- Published
- 2019
- Full Text
- View/download PDF
12. Cochlear Impairment and Autoimmune Ear Disorder in a Patient with Breast Cancer.
- Author
-
Fioretti A, Di Rubbo V, Peri G, Vitti E, Cisternino S, Varakliotis T, and Eibenstein A
- Abstract
The purpose of this study was to consider the possible role of autoimmune diseases and paraneoplastic syndrome in the genesis of tinnitus. The incidence of autoimmune inner ear disease (AIED) is rare, accounting for <1% of all cases of hearing impairment and dizziness. In presence of auditory and vestibular deficit in oncological patients, a paraneoplastic syndrome with cochleovestibulopathy should be considered. We described a 50-year-old Caucasian woman came to our attention with complaints of severe disabling bilateral tinnitus (Tinnitus Handicap Inventory, THI: 96), ear fullness and headache. The onset of tinnitus was associated to the last breast implant and prolonged antibiotic therapy. Serological autoimmunity tests were positive and a diagnosis of mixed connective tissue disease with notes of fibromyalgia was made . Pure tone audiometry testing revealed bilateral fluctuating mild hearing loss on high frequencies. The tinnitus was successfully treated with bilateral wideband sound generators (listening 8-9 h for day) regulated at the mixing point. At 12 months follow up THI has shrunk considerably (THI: 4) and the patient has continued treatment only with the sound pillow. In conclusion significant progress is needed to better understand the role of autoantibodies in the pathogenesis and diagnosis of paraneoplastic cochleovestibulopathy. To our knowledge, our study is the first in which hearing loss and tinnitus is considered as a manifestation of a paraneoplastic syndrome.
- Published
- 2017
- Full Text
- View/download PDF
13. Olfactory performance after crenotherapy in chronic rhinosinusitis in the elderly.
- Author
-
Cantone E, Maione N, Di Rubbo V, Esposito F, and Iengo M
- Subjects
- Adult, Aged, Case-Control Studies, Chronic Disease, Cohort Studies, Complementary Therapies adverse effects, Female, Humans, Longitudinal Studies, Male, Middle Aged, Olfaction Disorders etiology, Smell physiology, Surveys and Questionnaires, Treatment Outcome, Complementary Therapies methods, Olfaction Disorders physiopathology, Rhinitis therapy, Sinusitis therapy
- Abstract
Objective: To evaluate the effectiveness of crenotherapy on the olfactory performance of elderly patients with chronic rhinosinusitis (CRS)., Study Design: A longitudinal case-control study of a cohort of elderly patients affected by CRS and olfactory dysfunction assessed with the Sniffin' Sticks (Burghart Medical Technology, Wedel, Germany) (SS) olfactory test., Methods: One hundred and thirty-seven elderly subjects with CRS were divided into two groups. The investigational arm (n = 69) underwent crenotherapy with hyperthermal water, rich in mineral salts, and the control group (n = 68) underwent NaCl 0.9% both for 12 days. At baseline and at 1 and 6 months after treatment, both groups underwent ear nose and throat assessment and SS. Self-report questionnaires were administered at baseline to evaluate the patients' own olfactory response, and after treatment to evaluate their degree tolerability. Olfactory performance was then evaluated in elderly subjects with hyposmia without CRS (n = 40) and in younger subjects with both hyposmia and CRS (n = 40)., Results: No adverse reactions were reported after crenotherapy. The SS total score showed that crenotherapy induced a statistically significant improvement in the olfactory function of both the elderly and the younger subjects with hyposmia and CRS. By contrast, no improvement was observed in the control arm and in the elderly with hyposmia without CRS. All subjects showed a good degree of tolerability., Conclusions: We demonstrated that crenotherapy effectively improves olfactory function in elderly patients with CRS. Finally, our study suggests that crenotherapy represents a safe therapeutic strategy for the treatment of CRS and olfactory dysfunction in the elderly., (© 2015 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
14. Nasal cytological assessment after crenotherapy in the treatment of chronic rhinosinusitis in the elderly.
- Author
-
Cantone E, Marino A, Ferranti I, Castagna G, Maione N, Di Rubbo V, and Iengo M
- Subjects
- Aged, Chronic Disease, Female, Humans, Male, Middle Aged, Rhinitis pathology, Sinusitis pathology, Balneology methods, Nasal Mucosa pathology, Rhinitis therapy, Sinusitis therapy
- Abstract
Chronic rhinosinusitis (CRS) determines irreversible alterations of the nasal mucosa with consequent impairment of ciliary movements and, therefore, mucociliary clearance (MCC). People of all ages can be affected by CRS but the elderly are subjects at the highest risk. CRS in the elderly with an age-related physiological impairment of nasal respiratory function, often accompanied by other chronic diseases, requires additional therapies to be added to the numerous daily medications. Since the currently available therapies for CRS include the use of drugs that can have adverse effects and contraindications, crenotherapy could represent a therapeutic option. Indeed, because the adverse effects and contraindications of crenotherapy are scarce, it can be safely used in elderly patients with comorbidities. The aim of this study is to evaluate the nasal cytological assessment after crenotherapy in elderly subjects with CRS. Two groups, comprising a total of 84 elderly subjects with CRS, were treated with crenotherapy with sodium chloride sulphate hyperthermal water rich in mineral salts (group I, n=49) and saline solution (group II n=35). Cytological assessment for both groups took place at baseline (T0) and 1 month after treatment (T30). At T30 the nasal cytological assessment showed statistically significant improvements in the ciliary motility and in the count of neutrophils and spores in group I, but not in group II. Conversely, there were no significant differences in the count of eosinophils, mast cells, bacteria and biofilm in either group. Our data for the first time focused on the role of crenotherapy in the improvement of cytological assessment of CRS in the elderly.
- Published
- 2014
- Full Text
- View/download PDF
15. A novel approach to manage recurrent epistaxis in outpatients with hereditary hemorrhagic telangiectasia.
- Author
-
Cantone E, Marino A, Castagna G, Sicignano S, Rega F, Di Rubbo V, and Iengo M
- Subjects
- Administration, Intranasal, Epistaxis etiology, Female, Gelatin administration & dosage, Gelatin therapeutic use, Genetic Diseases, Inborn etiology, Humans, Male, Middle Aged, Recurrence, Telangiectasia, Hereditary Hemorrhagic therapy, Thrombin administration & dosage, Thrombin therapeutic use, Treatment Outcome, Epistaxis therapy, Genetic Diseases, Inborn therapy, Hemostatic Techniques, Telangiectasia, Hereditary Hemorrhagic complications
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.